Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros








Intervalo de ano de publicação
1.
Int J Mol Sci ; 24(10)2023 May 22.
Artigo em Inglês | MEDLINE | ID: mdl-37240413

RESUMO

Alzheimer's disease (AD) is a chronic neurodegenerative disease and the most frequent cause of progressive dementia in senior adults. It is characterized by memory loss and cognitive impairment secondary to cholinergic dysfunction and N-methyl-D-aspartate (NMDA)-mediated neurotoxicity. Intracellular neurofibrillary tangles, extracellular plaques composed of amyloid-ß (Aß), and selective neurodegeneration are the anatomopathological hallmarks of this disease. The dysregulation of calcium may be present in all the stages of AD, and it is associated with other pathophysiological mechanisms, such as mitochondrial failure, oxidative stress, and chronic neuroinflammation. Although the cytosolic calcium alterations in AD are not completely elucidated, some calcium-permeable channels, transporters, pumps, and receptors have been shown to be involved at the neuronal and glial levels. In particular, the relationship between glutamatergic NMDA receptor (NMDAR) activity and amyloidosis has been widely documented. Other pathophysiological mechanisms involved in calcium dyshomeostasis include the activation of L-type voltage-dependent calcium channels, transient receptor potential channels, and ryanodine receptors, among many others. This review aims to update the calcium-dysregulation mechanisms in AD and discuss targets and molecules with therapeutic potential based on their modulation.


Assuntos
Doença de Alzheimer , Doenças Neurodegenerativas , Humanos , Doença de Alzheimer/patologia , Cálcio/metabolismo , Peptídeos beta-Amiloides/metabolismo , Cálcio da Dieta , Canais de Cálcio Tipo L
2.
Rev. colomb. ciencias quim. farm ; 44(3): 322-358, Sept.-Dec. 2015. ilus, graf, mapas, tab
Artigo em Espanhol | LILACS | ID: lil-781919

RESUMO

El sistema opioide, del cual forman parte los peptidos opioides endogenos y sus receptores (Miu, Kappa, delta y ORL), tiene un papel importante en la fisiologia de diferentes sistemas. Existe una creciente evidencia de su participacion en la fisiopatologia de multiples trastornos del sistema nervioso central, endocrino e inmunologico. La modulacion del sistema opioide mediante el uso de antagonistas especificos o inespecificos de sus receptores puede tener un papel terapeutico en el manejo sintomatico de diferentes contextos, incluyendo la intoxicacion aguda por opiaceos, la dependencia a opioides, y la reduccion de reacciones adversas de agonistas opioides utilizados en el manejo del dolor cronico. El presente trabajo tiene como objetivo revisar la farmacologia de los antagonistas opioides especificos e inespecificos, y realizar una actualizacion de sus posibles nuevas indicaciones y usos terapeuticos.


Opioid system, which involved endogenous opioid peptides and their receptors (Miu, Kappa, delta and ORL), has a main role in the physiology of several systems. At the same time, there is cumulating evidence in the role of the opioid system in the physiopathology of several disorders in the central nervous, endocrine and immunological system. The modulation of the opioid system using nonspecific antagonists may have a therapeutic role in the symptomatic management of several diseases, as well as, in the emergency management of opioid analgesic overdose, opioid dependence and to reduce the drug side effects of the opioid agonists used in chronic pain. This paper aims to review the pharmacology of specific and nonspecific opioid antagonists, and update on possible new indications and therapeutic uses of such antagonists.

3.
Rev. salud pública ; 10(2): 315-321, mar.-mayo 2008. tab
Artigo em Espanhol | LILACS | ID: lil-497371

RESUMO

Objetivo El objetivo del presente estudio consistió en determinar la prevalencia de las reacciones adversas a medicamentos (RAM) como motivo de consulta a un servici -o de atención prioritaria. Métodos El estudio se realizó en el servicio de atención prioritaria del Centro de Atención Ambulatoria Central Luis de la ESE Luis Carlos Galán Sarmiento en Bo- gotá , del 20 de septiembre al 2 de octubre de 2004. Las RAM fueron identificadas por un evaluador, quien revisó todas las historias clínicas y cada vez que los médi -cos señalaron la sospecha de una RAM. Los pacientes fueron contactados. La eva - luación de la causalidad, prevenibilidad , y mecanismo de generación fue realizada por dos evaluadores. Resultados La prevalencia de RAM fue de 45 RAM en 1 395 consultas, en dos semanas (2,8 por ciento de las consultas). El reporte espontáneo modificado permitió de- tectar el 26,7 por ciento de las RAM identificadas por búsqueda activa. Del total de las RAM identificadas el 73,3 por ciento se presentó en mujeres, 64,9 por ciento en mayores de 60 años, 48,9 por ciento fueron no prevenibles, 22,2 por ciento prevenibles y 28,9 por ciento inclasificables. Conclusiones Las RAM representan una proporción significativa de la consulta ambulatoria y el sistema de reporte espontáneo modificado detectó un gran porcen -taje de RAM. La distribución y tipo de RAM fueron similares a las descritas en otras series. Aproximadamente 2 de cada 10 RAM pudieron haberse prevenido.


Objective Determining the prevalence of adverse drug reactions (ADR) as the reason for visiting an emergency department. Methods The study took place at the Luis Carlos Galán Sarmiento ESE's Emergency Department's Central Outpatient Centre in Bogotá. It was carried out from September 20 th to October 2 nd 2004. ADR were identified by an evaluator who reviewed all clinical histories, noting when physicians had indicated that an ADR had occurred. The patients were contacted. Two people evaluated causality, the degree of preventability and the mechanism producing the ADR. Results 45 ADR were recorded in 1,395 visits made during a two-week period (2.8 percent of the consultations). Modified spontaneous report detected 26.7 percent ADR identified by active search. 73.3 percent of all identified ADR occurred in females, 64.9 percent in people older than 60. 48.9 percent were non-preventable, 22.2 percent preventable and 28.9 percent were unclassifiable. Conclusions ADR represent a significant proportion of the reasons for outpatient consultation; the modified spontaneous report system detected a large percentage of ADR. There were no statistically significant differences between gender and ADR frequency. ADR occurred more frequently in elderly patients. Around 2 out of each 10 ADR could have been prevented.


Assuntos
Adolescente , Adulto , Idoso de 80 Anos ou mais , Criança , Pré-Escolar , Feminino , Humanos , Lactente , Recém-Nascido , Masculino , Pessoa de Meia-Idade , Sistemas de Notificação de Reações Adversas a Medicamentos , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos , Farmacoepidemiologia , Colômbia/epidemiologia , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos/epidemiologia , Serviço Hospitalar de Emergência , Pacientes Ambulatoriais , Projetos Piloto
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA